Dr. Dongliang Chang is our founder and has served as the chairman of our board of directors since our inception. Dr. Chang is a renowned expert in biochemistry and has been instrumental to the growth and success of our Company. His research focuses on organic synthesis, bioinformatics, heterocyclic intermediates and bio-catalysis. Dr. Chang has published more than 30 articles in publications including, among others, Biocatalysis and Biotransformation, The Journal of Organic Chemistry and Chemical Communications, and has received 11 patents. Dr. Chang received his doctorate degree in biotechnology from the Swiss Federal Institute of Technology in 2004.
Dr. Zheng Wang has served as our chief executive officer since 2018 and our director since October 2019. Dr. Wang has more than 20 years’ experience in operation management. Prior to joining us, Dr. Wang served as the chief executive officer of XinQi Biotechnology Inc. from 2006 to 2012. From 2001 to 2006, he served as the supervisor of China Investment Group, a South Korean company. Dr. Wang received his bachelor’s degree, master’s degree and doctorate degree from Shanghai Second Medical University in 1991, 1998 and 2001, respectively.
Mr. Zhaohong Li has served as our chief financial officer since April 2019. He has served as a director of Harvest Year Asia since 2017. He was the vice president of Zhejiang Xinyuan Holding Co., Ltd and the chief financial officer of the technology group of Xinyuan Group in 2018 and the deputy director of investment department of Cross-strait Tsinghua Research Institute from 2017 to 2018. Prior to that, Mr. Li served as the senior director at China International Marine Containers Group Ltd. from 2015 to 2016. From 2011 to 2015, he served as the head of China at 360ip Pte Ltd. In 2010, Mr. Li served as the assistant to the CEO, managing director and the head of investment department at BOCGI Zheshang Capital Co. Ltd. Mr. Li received his bachelor’s degree in engineering and applied sciences from California Institute of Technology in 1991 and his Master of Management from Northwestern University’s Kellogg School of Management in 1998.
Mr. Qiaoqiao Sun has served as our co-chief financial officer since September 2019 and as our financial officer from 2018 to September 2019. Prior to joining us, he served as the vice general manager of the finance department at Wanda Network Technology Group from 2016 to 2018. From 2015 to 2016, he served as the financial director at Lvnengbao Group, in charge of the financial department of the internet business group. From 2013 to 2015, he served as the finance manager at China Everbright Limited, in charge of the financial department of the Shanghai region. From 2011 to 2013, he served as the accounting manager at Fosun Pharma Group. Mr. Sun received his bachelor’s degree from Shanghai University of Finance and Economics in 2004 and his master’s degree from Shanghai Jiaotong University in 2015.